Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
Clinical trial NCT04546074 · UNKNOWN
Trial details
- NCT number
- NCT04546074
- Sponsor
- Keio University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2024-10-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.